Pfizer Recalls Blood Pressure Drug Accuretic in UK Due to Nitrosamine Risk

Pfizer has recalled a single batch of its blood pressure drug, Accuretic (quinapril HCl/hydrochlorothiazide), in the UK following the detection of a nitrosamine contaminant, N-nitroso-quinapril, at levels above the acceptable limit.

The batch of concern, numbered DD4842, was for quinapril HCl 10 mg/ hydrochlorothiazide 12.5 mg film-coated tablets distributed in April 2020.

Consumption of nitrosamine at amounts above acceptable levels long-term could lead to an increased risk of cancer.

The recall will affect Accuretic supply at the wholesaler and pharmacy levels, the company said.